Koers Quick-Med Technologies, Inc. Other OTC
Aandelen
QMDT
US74837Q1067
Biotechnologie & Medisch Onderzoek
Omzet 2012 | 997K 932K | Omzet 2013 | 928K 868K | Marktkapitalisatie | 2,28 mln. 2,13 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2012 | -1 mln. -934K | Nettowinst (verlies) 2013 | - 0 | EV/omzet 2012 | 10,8 x |
Nettoschuld 2012 | 7,43 mln. 6,95 mln. | Nettoschuld 2013 | 7,86 mln. 7,34 mln. | EV/omzet 2013 | 10,9 x |
K/w-verhouding 2012 |
-1,99
x | K/w-verhouding 2013 |
-3,19
x | Werknemers | - |
Dividendrendement 2012 * |
-
| Dividendrendement 2013 |
-
| Vrij verhandelbaar | 100% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Bernd Liesenfeld
PSD | President | 53 | 01-01-04 |
William Toreki
CTO | Chief Tech/Sci/R&D Officer | - | 01-01-02 |
Gregory Schultz
BRD | Director/Board Member | 73 | 01-07-00 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Gerald Olderman
BRD | Director/Board Member | 90 | 01-07-97 |
Gregory Schultz
BRD | Director/Board Member | 73 | 01-07-00 |
Dale Bergman
BRD | Director/Board Member | 67 | 28-02-13 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+23,13% | 46,93 mld. | |
+37,21% | 39,08 mld. | |
-8,73% | 38,48 mld. | |
+28,09% | 31,01 mld. | |
-12,26% | 26,14 mld. | |
+10,57% | 25,88 mld. | |
+32,23% | 12,53 mld. | |
-6,56% | 11,36 mld. | |
-12,56% | 10,65 mld. |